[HTML][HTML] Resting-state fMRI in predicting response to treatment with SSRIs in first-episode, drug-naive patients with major depressive disorder
A Zhang, X Wang, J Li, L Jing, X Hu, H Li… - Frontiers in …, 2022 - frontiersin.org
Objective For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
[HTML][HTML] Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
A Zhang, X Wang, J Li, L Jing, X Hu, H Li… - Frontiers in …, 2022 - frontiersin.org
Objective For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
[HTML][HTML] Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
A Zhang, X Wang, J Li, L Jing, X Hu, H Li… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Objective For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder.
A Zhang, X Wang, J Li, L Jing, X Hu, H Li… - Frontiers in …, 2022 - europepmc.org
Objective For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
A Zhang, X Wang, J Li, L Jing, X Hu… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
[引用][C] Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
A Zhang, X Wang, J Li, L Jing, X Hu, H Li… - Frontiers in …, 2022 - jglobal.jst.go.jp
Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive
Patients With Major Depressive Disorder | Article Information | J-GLOBAL Art J-GLOBAL ID:202202253417382787 …
Patients With Major Depressive Disorder | Article Information | J-GLOBAL Art J-GLOBAL ID:202202253417382787 …
Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder.
A Zhang, X Wang, J Li, L Jing, X Hu… - Frontiers in …, 2022 - search.ebscohost.com
Objective: For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder.
A Zhang, X Wang, J Li, L Jing, X Hu, H Li… - Frontiers in …, 2022 - europepmc.org
Objective For major depressive disorder (MDD), there has been a lack of neuroimaging
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …
markers of efficacy of pharmacological treatment. In this study, we aimed to explore the …